05/29/2026
How can the industry make clinical trial information more accessible?
In part one of this series, Andrelia Allen and Rebecca Johnson, PhD, of Merck discuss representation in clinical trial ex*****on and the importance of making clinical trial information more accessible and familiar to communities.
Watch part one in the comments 👇